Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Preliminary Results: Correction

21 Mar 2019 09:00

RNS Number : 5148T
Impellam Group plc
21 March 2019
 

 

 

 

 

PRELIMINARY RESULTS - UNAUDITED

 CORRECTION

 

Impellam Group plc ("Impellam" or ''the Group'') - London AIM: IPEL: 21 March 2019

 

Further to its preliminary unaudited results announcement released on 14 March 2019, the Company wishes to make the following amendments in respect of adjusted EPS, which was under-stated in that announcement due to the treatment of deferred tax on the adjustments to profit - primarily the impairment of goodwill. The correction results in the following increases to adjusted EPS and adjusted profit as follows:

 

 

 

FY 2018

FY 2017

Actual Inc/(Dec)

 

Previously Reported

 

 

 

 

 

 

 

 

 

Adjusted Basic EPS (1)

 

56.8p

74.6p

(23.9)%

 

 

 

 

 

Corrected

 

Adjusted Basic EPS (1)

 

60.8p

75.2p

(19.1)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Before separately disclosed items, impairment, customer relationship amortisation and share-based payments. Explanation of this Alternative Performance Measure is below

 

 

Alternative Performance Measures

 

Adjusted earnings per share (EPS)

Definition: Adjusted profit divided by the weighted average number of ordinary shares outstanding during the year.

Closest equivalent IFRS measure: Basic earnings per share

Rationale for adjustment: The Group uses this measure alongside the basic EPS calculation as it reflects the underlying trading performance of the business.

 

 

 

The corrected tables below reflect an increase in impairment of goodwill (the adjustment was previously shown net of tax but is now shown as the gross value), as well as higher customer relationship amortisation, resulting in higher adjusted profit and EPS.

Reconciliation of Adjusted EPS to Basic EPS:

 

2018

2017

 

£m

£m

Profit for the period

13.3

31.1

Separately disclosed items (net of tax)

4.9

3.3

Impairment of goodwill

8.6

-

Customer relationship amortisation (net of tax)

3.7

3.4

Adjusted profit

30.5

37.8

 

 

 

Weighted average number of shares

50,171,830

50,322,196

 

 

 

Basic EPS

26.5

61.9

Adjusted EPS

60.8

75.2

 

The Company expects to issue its audited annual report later today, which will be made available on the Company's website at www.impellam.com

 

[END]

 

For further information please contact:

 

Impellam Group plc

Julia Robertson, Group Chief Executive Tel: + 44 (0)1582 692658

 

Cenkos Securities plc (NOMAD and Corporate Broker to Impellam)

Nicholas Wells Tel: +44 (0)20 7397 8900

Callum Davidson

 

Note to Editors:

 

Impellam is the second largest1 staffing business in the UK and sixth largest2 managed services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

 

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 17 market-leading brands across 165 worldwide locations.

 

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

 

For more information about Impellam Group please visit: www.impellam.com

 

1 By revenue (2017 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts). Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2017 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURJMMTTMBATTAL
Date   Source Headline
24th Sep 20195:47 pmRNSTransaction in Own Shares
19th Sep 20199:39 amRNSTransaction in Own Shares
23rd Aug 20194:46 pmRNSTransaction in Own Shares
8th Aug 20197:00 amRNSTransaction in Own Shares
30th Jul 20197:00 amRNSHalf-year Report
15th Jul 20197:00 amRNSTransaction in Own Shares
9th Jul 20197:00 amRNSAcquisition of AI Powered Staffing Platform
26th Jun 20199:51 amRNSResult of AGM
25th Jun 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jun 20197:00 amRNSTransaction in Own Shares
24th May 20194:50 pmRNSTransaction in Own Shares
8th May 20194:50 pmRNSTransaction in Own Shares
24th Apr 20193:59 pmRNSTransaction in Own Shares
28th Mar 20197:00 amRNSTransaction in Own Shares
21st Mar 20199:00 amRNSPreliminary Results: Correction
21st Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSPreliminary Results - Unaudited
13th Mar 20195:41 pmRNSTransaction in Own Shares
28th Feb 20197:00 amRNSTransaction in Own Shares
20th Feb 20197:00 amRNSDemerger of Carlisle Support Services
14th Feb 20194:21 pmRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20194:29 pmRNSTransaction in Own Shares
21st Dec 20184:18 pmRNSTransaction in Own Shares
5th Dec 20185:02 pmRNSTransaction in Own Shares
14th Nov 20183:36 pmRNSTransaction in Own Shares & Total Voting Rights
13th Nov 20183:04 pmRNSTransaction in Own Shares
8th Nov 20187:00 amRNSTransaction in Own Shares
31st Oct 20187:00 amRNSTransaction in Own Shares
15th Oct 20187:00 amRNSTransaction in Own Shares
8th Oct 20187:00 amRNSTransaction in Own Shares
27th Sep 20185:21 pmRNSTransaction in Own Shares
27th Sep 20184:41 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
27th Sep 20187:00 amRNSDirectorate Change
27th Sep 20187:00 amRNSTrading Statement
22nd Aug 201812:51 pmRNSTransaction in Own Shares
26th Jul 20187:00 amRNSHalf-year Report
21st Jun 201810:05 amRNSResult of AGM
5th Jun 20184:47 pmRNSTransaction in Own Shares and Total Voting Rights
31st May 20187:00 amRNSDirectorate Change
10th May 201812:14 pmRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20186:23 pmRNSHolding(s) in Company
24th Apr 20183:02 pmRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20187:00 amRNSTransaction in Own Shares
20th Mar 20185:17 pmRNSHolding(s) in Company
20th Mar 20185:14 pmRNSDirector/PDMR Shareholding
16th Mar 201810:12 amRNSAnnual Financial Report
8th Mar 20187:00 amRNSPreliminary Results - Unaudited
19th Feb 20183:22 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20184:47 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.